Friulchem spa

Investor Relations

FRIULCHEM REPORTS ON PATENT RULING FOR RIFAXIMIN

DCAT Value Chain Insights published a new article on Patent Ruling for Rifaximin.

Mexican Institute of Industrial Property (IMPI), the patent and trademark administration body of Mexico, recently dismissed a patent-infringement and unfair competition case filed against Interquim, S.A. de C.V.

Read more

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top